A. Dupuy

6.9k total citations
133 papers, 3.4k citations indexed

About

A. Dupuy is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, A. Dupuy has authored 133 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 39 papers in Dermatology and 29 papers in Epidemiology. Recurrent topics in A. Dupuy's work include Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (12 papers) and Psoriasis: Treatment and Pathogenesis (12 papers). A. Dupuy is often cited by papers focused on Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (12 papers) and Psoriasis: Treatment and Pathogenesis (12 papers). A. Dupuy collaborates with scholars based in France, United States and Belgium. A. Dupuy's co-authors include Richard Simon, S. Vignes, M. Arrault, Raphaël Porcher, Patrice Morel, O. Chosidow, Célèste Lebbé, H. Bachelez, C. Droitcourt and M. Rybojad and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

A. Dupuy

120 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Dupuy France 31 916 694 693 582 512 133 3.4k
Christian Grønhøj Denmark 31 1.1k 1.2× 777 1.1× 486 0.7× 499 0.9× 694 1.4× 99 4.6k
Syed A. Hoda United States 31 1.2k 1.3× 772 1.1× 565 0.8× 518 0.9× 1.3k 2.4× 174 5.2k
Michael Bigby United States 30 496 0.5× 799 1.2× 471 0.7× 1.1k 1.9× 373 0.7× 102 4.9k
Edward Odell United Kingdom 42 862 0.9× 1.2k 1.8× 387 0.6× 322 0.6× 1.2k 2.3× 242 6.4k
Graeme R. Russ Australia 38 1.0k 1.1× 541 0.8× 717 1.0× 172 0.3× 1.3k 2.5× 132 4.7k
Geir E. Tjønnfjord Norway 37 680 0.7× 722 1.0× 298 0.4× 250 0.4× 859 1.7× 217 5.7k
Maryam M. Asgari United States 35 1.8k 1.9× 555 0.8× 1.3k 1.9× 1.4k 2.3× 279 0.5× 141 4.0k
P. Sève France 44 1.2k 1.3× 1.5k 2.2× 611 0.9× 180 0.3× 845 1.7× 280 6.9k
Evan R. Farmer United States 37 1.2k 1.3× 1.0k 1.5× 1.4k 2.0× 1.5k 2.6× 357 0.7× 97 4.6k
Kevin M. Elias United States 30 761 0.8× 805 1.2× 460 0.7× 126 0.2× 1.0k 2.0× 152 4.6k

Countries citing papers authored by A. Dupuy

Since Specialization
Citations

This map shows the geographic impact of A. Dupuy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dupuy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dupuy more than expected).

Fields of papers citing papers by A. Dupuy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Dupuy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dupuy. The network helps show where A. Dupuy may publish in the future.

Co-authorship network of co-authors of A. Dupuy

This figure shows the co-authorship network connecting the top 25 collaborators of A. Dupuy. A scholar is included among the top collaborators of A. Dupuy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Dupuy. A. Dupuy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amici, Mara De, Érik Neveu, F. Poizeau, et al.. (2025). The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study. Annales de Dermatologie et de Vénéréologie. 152(2). 103371–103371.
2.
3.
Gall, François Le, Marie‐Dominique Vignon‐Pennamen, Solène‐Florence Kammerer‐Jacquet, et al.. (2024). Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome. Clinical and Experimental Dermatology. 49(8). 825–833. 5 indexed citations
4.
Maruani, A., S. Barbarot, C. Abasq, et al.. (2023). Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014–2021 French Ouest DataHub. Annales de Dermatologie et de Vénéréologie. 150(3). 189–194. 3 indexed citations
5.
Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2023). Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Annales de Dermatologie et de Vénéréologie. 150(2). 101–108. 1 indexed citations
6.
Poizeau, F., Frédéric Balusson, F. Lemaı̂tre, et al.. (2023). The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma. British Journal of Dermatology. 188(4). 482–490. 2 indexed citations
7.
8.
Poizeau, F., Sandrine Kerbrat, Frédéric Balusson, et al.. (2022). The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving Immunotherapy. JNCI Journal of the National Cancer Institute. 114(5). 686–694. 13 indexed citations
9.
Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2021). Impact de l’épidémie de COVID-19 lors de la 1ère vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané. PubMed Central. 1(8). A298–A299. 1 indexed citations
10.
Poizeau, F., Emmanuel Oger, S. Barbarot, et al.. (2021). Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case–control study. Clinical Microbiology and Infection. 28(2). 285–291. 6 indexed citations
11.
Siebert, Maximilian, et al.. (2020). Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations. BMJ Open. 10(5). e038887–e038887. 29 indexed citations
12.
Poizeau, F., Sandrine Kerbrat, André Happe, et al.. (2020). Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017. Journal of Investigative Dermatology. 141(4). 830–839.e3. 8 indexed citations
13.
Barbarot, S., F. Poizeau, E. Mahé, et al.. (2020). Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis. British Journal of Dermatology. 183(2). 376–378.
14.
Lancar, Rémi, et al.. (2020). Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study. Acta Dermato Venereologica. 100(17). adv00292–adv00292. 12 indexed citations
15.
Russo, Domenico, F. Poizeau, R. Baggio, et al.. (2020). 1133P Skin photoaging around the site of occurrence of primary melanoma as a clinical predictive biomarker of response to PD-1 inhibitors. Annals of Oncology. 31. S760–S760. 1 indexed citations
16.
Oger, Emmanuel, S. Buche, M. Delage, et al.. (2019). Concordance of severity scores for photographic assessment of hidradenitis suppurativa. British Journal of Dermatology. 182(2). 515–516.
17.
Droitcourt, C., M. Rybojad, Raphaël Porcher, et al.. (2014). A Randomized, Investigator-Masked, Double-Blind, Placebo-Controlled Trial on Thalidomide in Severe Cutaneous Sarcoidosis. CHEST Journal. 146(4). 1046–1054. 29 indexed citations
18.
Beaussant-Cohen, Sarah, Odile Fenneteau, Emmanuel Plouvier, et al.. (2012). Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet Journal of Rare Diseases. 7(1). 71–71. 80 indexed citations
19.
Lebrun‐Vignes, Bénédicte, Anissa Bouzamondo, A. Dupuy, et al.. (2007). A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. Journal of the American Academy of Dermatology. 57(2). 238–246. 30 indexed citations
20.
Vignes, S., M. Arrault, & A. Dupuy. (2007). Factors associated with increased breast cancer-related lymphedema volume. Acta Oncologica. 46(8). 1138–1142. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Grønhøj Breakdown of academic impact, for papers by Syed A. Hoda Breakdown of academic impact, for papers by Michael Bigby Breakdown of academic impact, for papers by Edward Odell Breakdown of academic impact, for papers by Graeme R. Russ Breakdown of academic impact, for papers by Geir E. Tjønnfjord Breakdown of academic impact, for papers by Maryam M. Asgari Breakdown of academic impact, for papers by P. Sève Breakdown of academic impact, for papers by Evan R. Farmer Breakdown of academic impact, for papers by Kevin M. Elias
Rankless by CCL
2026